Impact of microbial physiology and microbial community structure on pharmaceutical fate driven by dissolved oxygen concentration in nitrifying bioreactors.
Operation at low dissolved oxygen (DO) concentrations (<1 mg/L) in wastewater treatment could save utilities significantly by reducing aeration energy costs. However, few studies have evaluated the impact of low DO on pharmaceutical biotransformations during treatment. DO concentration can impact pharmaceutical biotransformation rates during wastewater treatment both directly and indirectly: directly by acting as a limiting substrate that slows the activity of the microorganisms involved in biotransformation; and indirectly by shaping the microbial community and selecting for a community that performs pharmaceutical biotransformation faster (or slower). In this study, nitrifying bioreactors were operated at low (∼0.3 mg/L) and high (>4 mg/L) DO concentrations to understand how DO growth conditions impacted microbial community structure. Short-term batch experiments using the biomass from the parent reactors were performed under low and high DO conditions to understand how DO concentration impacts microbial physiology. Although the low DO parent biomass had a lower specific activity with respect to ammonia oxidation than the high DO parent reactor biomass, it had faster biotransformation rates of ibuprofen, sulfamethoxazole, 17α-ethinylestradiol, acetaminophen, and atenolol in high DO batch conditions. This was likely because the low DO reactor had a 2x higher biomass concentration, was enriched for ammonia oxidizers (4x higher concentration), and harbored a more diverse microbial community (3x more unique taxa) as compared to the high DO parent reactor. Overall, the results show that there can be indirect benefits from low DO operation over high DO operation that support pharmaceutical biotransformation during wastewater treatment.